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PROGNOSTIC SIGNIFICANCE
OF VISCERAL PLEURAL
INVASION AND TUMOR SIZE IN
NON–SMALL CELL LUNG
CANCER
To the Editor:
We read with great interest the article
byShimizu and colleagues1 published in
the July 2005 issue of the Journal. They
found that visceral pleural invasion
(VPI) is a significant poor prognostic
factor of non–small cell lung cancer
(NSCLC), regardless of N status. Stage
I NSCLC has been subdivided into IA
(T1N0M0) and IB (T2N0M0) based on
tumor size (3 cm as a cutoff value) and
non–size-based T2 descriptors (includ-
ingVPI, hilar atelectasis, andobstructive
pneumonitis).2 Although a poor prog-
nostic effect of VPI has generally been
reported, its prognostic value for
survival has remained controversial.3,4
Letters to the EditorPERCUTANEOUS AORTIC
VALVE IMPLANTATION: WHAT
DOES OVERSIZING MEAN?
To the Editor:
We read with interest the recent
article by Litzler and colleagues1 in
the Journal of Thoracic and Cardio-
vascular Surgery.The authors reported
their first case of emergency surgical
aortic valve replacement for severe
acute aortic regurgitation after retro-
grade transfemoral Cribier-Edwards
valve implantation.
We would like to comment on this
instructive case report and ask for
some clarifications:
When valved stent implantation is
planned in a patient, accurate pre-
procedural determination of the aortic
annulus size is of crucial importance.
A prosthesis–aortic annulus mismatch
may be responsible for valve migra-
tion or severe paravalvular leak if the
chosen prosthesis is too small and for
coronary obstruction or leaflet distor-
tion if it is too large.2
The incidence of paravalvular leak
has been shown to be dramatically
high in previous studies.3,4 To reduce
the incidence and severity of paravalvu-
lar leak, the oversizing technique (ie, the
choice of a prosthesis size at least 2 mm
more than that of the aortic annulus di-
ameter as determined by transthoracic
echocardiography [TTE]) has been pro-
posed and proved to be effective.4
Nevertheless, several previous stud-
ies have shown that measurement of
the aortic annulus diameter by TTE is
inaccurate when compared with surgi-
cal sizing.5 TTE tends to underesti-260 The Journal of Thoracic and Cmate by up to 5 mm (3 mm in this
case report) the size of the aortic annu-
lus. In the present case, the chosen size
of the implanted valve was 23 mm.
The latter was supposed to be over-
sized based on the TTEmeasurements.
The surgically implanted valve was
also 23 mm based on the surgical mea-
surements. Despite ‘‘oversizing’’ in
this reported percutaneous valve im-
plantation, severe paravalvular leak
occurred, which means, in a sense,
that this strategy has not solved this
major problem at the present time.
We would like to ask the authors
a few questions:
 What does ‘‘oversizing’’ mean for
them in the choice of the implant-
able valve ? Is oversizing based on
the TTE measurements of the aortic
annulus diameter or is it based on
the ‘‘true’’ aortic annulus diameter
if the latter could be measured?
 Do they still rely on TTE for deter-
mination of the aortic annulus diam-
eter or have they changed their
imaging technique?
 Have they changed the magnitude
of oversizing, based on this reported
experience?
 If so, how effective is their new ap-
proach regarding the occurrence of
paravalvular leak?
Optimal sizing of valved stents
remains a critical issue with many im-
plications on the post-procedural
course. The readers of the Journal
would greatly appreciate the answers
to these ‘‘practical’’ questions from
one of the most experienced teams in
interventional aortic valve therapy.
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